Show simple item record

dc.creatorPark, Jason S.
dc.creatorHamilton, Caitlin D.
dc.creatorPatel, Shaan
dc.creatorLee, Jason B.
dc.creatorHsu, Sylvia
dc.date.accessioned2023-01-06T17:20:46Z
dc.date.available2023-01-06T17:20:46Z
dc.date.issued2022-10-14
dc.identifier.citationPark J S, Hamilton C D, Patel S, et al. (October 14, 2022) Linear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome. Cureus 14(10): e30309. doi:10.7759/cureus.30309
dc.identifier.issn2168-8184
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/8209
dc.identifier.urihttp://hdl.handle.net/20.500.12613/8238
dc.description.abstractLinear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease characterized by linear IgA deposition along the dermo-epidermal junction on direct immunofluorescence (DIF). LABD appears clinically as erythematous polycyclic lesions in younger patients but can show considerable phenotypic heterogeneity in older patients, often leading to misdiagnoses such as bullous pemphigoid, pemphigus vulgaris, Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), or other bullous conditions. Cases of LABD mimicking SJS/TEN require prompt skin biopsies for histopathology and DIF for disease differentiation and medical decision-making. In cases of suspected drug-induced LABD or SJS/TEN, identification and removal of the offending agent are paramount. The preferred treatment for LABD is oral dapsone, while SJS/TEN may respond better to cyclosporine or a combination of intravenous immunoglobulin and systemic corticosteroids. This case highlights the rare occurrence of LABD mimicking SJS/TEN and emphasizes the details that clinicians must know to guide patient management.
dc.format.extent5 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/Researcher Works
dc.relation.haspartCureus, Vol. 14, No. 10
dc.relation.isreferencedbySpringer Nature
dc.rightsAttribution CC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectDermatology
dc.subjectInternal medicine
dc.subjectTherapeutics
dc.titleLinear Immunoglobulin A (IgA) Bullous Dermatosis Mimicking Stevens-Johnson Syndrome
dc.typeText
dc.type.genreJournal article
dc.description.departmentDermatology
dc.relation.doihttps://doi.org/10.7759/cureus.30309
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeLewis Katz School of Medicine
dc.creator.orcidHsu|0000-0001-7885-3730
dc.temple.creatorPark, Jason S.
dc.temple.creatorHamilton, Caitlin D.
dc.temple.creatorPatel, Shaan
dc.temple.creatorHsu, Sylvia
refterms.dateFOA2023-01-06T17:20:46Z


Files in this item

Thumbnail
Name:
ParkEtAl-JournalArticle-2022.pdf
Size:
1.616Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY